These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 921255

  • 1. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.
    Silver MS, Counts GW, Zeleznik D, Turck M.
    Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255
    [Abstract] [Full Text] [Related]

  • 2. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ, Washington JA.
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria.
    Shadomy S, Wagner G, Carver M.
    Antimicrob Agents Chemother; 1977 Nov; 12(5):609-13. PubMed ID: 921258
    [Abstract] [Full Text] [Related]

  • 4. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT, Chao HP, Ho SW, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activity of cefaclor (author's transl)].
    Knothe H.
    Infection; 1979 Feb; 7 Suppl 6():518-26. PubMed ID: 45087
    [Abstract] [Full Text] [Related]

  • 6. Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.
    Leitner F, Goodhines RA, Buck RE, Price KE.
    J Antibiot (Tokyo); 1979 Jul; 32(7):718-26. PubMed ID: 541265
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J, Levison ME.
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
    Tomatsu K, Ando S, Masuyoshi S, Kondo S, Hirano M, Miyaki T, Kawaguchi H.
    J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
    [Abstract] [Full Text] [Related]

  • 9. Biophotometric comparison of cephalexin and cephradine against gram-positive bacteria.
    Brumfitt W, Hamilton-Miller JM.
    Chemotherapy; 1982 Aug; 28(1):40-5. PubMed ID: 7035090
    [Abstract] [Full Text] [Related]

  • 10. [In vitro activity of oral cephalosporins (author's transl)].
    Wiedemann B, Flensberg T.
    Infection; 1979 Aug; 7 Suppl 6():551-3. PubMed ID: 399247
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
    Sinai R, Hammerberg S, Marks MI, Pai CH.
    Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
    Kamimura T, Kojo H, Matsumoto Y, Mine Y, Goto S, Kuwahara S.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017
    [Abstract] [Full Text] [Related]

  • 13. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN, Fuchs PC, Thornsberry C, Barry AL, Gavan TL, Gerlach EH.
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A pharmacological and in vitro comparison of three oral cephalosporins.
    Wise R, Andrews JM, Dean S, Welling PG, Kendall MJ.
    J Antimicrob Chemother; 1979 Sep; 5(5):601-7. PubMed ID: 115833
    [Abstract] [Full Text] [Related]

  • 17. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
    Welling PG, Dean S, Selen A, Kendall MJ, Wise R.
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
    Jones RN, Barry AL, Pfaller M, Allen SD, Ayers LW, Fuchs PC.
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):59-63. PubMed ID: 3370932
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C.
    Infection; 1987 Jan; 15(2):122-4. PubMed ID: 3596808
    [Abstract] [Full Text] [Related]

  • 20. Comparative in-vitro activity of a new oral carbacephem, LY163892.
    Howard AJ, Dunkin KT.
    J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.